| 1Tryptic Digest of Infliximab |
|---|
Analyte not found
Applications
Infliximab Peptide Mapping with Tryptic Digest on bioZen 1.6 µm Peptide PS-C18
25057
Separation Mode: Reversed Phase
Reversed Phase
Peptide PS-C18
HPLC
Pharmaceutical/Biopharmaceutical
Therapeutic / Clinical
Therapeutic / Clinical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 25057)
Column: | ||||||||||||||||||||||||
Brand Name: | ||||||||||||||||||||||||
Part No: | ||||||||||||||||||||||||
Phase Name: Peptide PS-C18 | ||||||||||||||||||||||||
Elution Type: Gradient | ||||||||||||||||||||||||
Mobile Phase: A: 0.1% Formic acid in water B: 0.1% Formic acid in acetonitrile | ||||||||||||||||||||||||
Gradient Profile:
| ||||||||||||||||||||||||
Flow Rate: 0.3 mL/min | ||||||||||||||||||||||||
Temperature: 40°C | ||||||||||||||||||||||||
System: Agilent Technologies 1290 Infinity Agilent Technologies 1290 Infinity | ||||||||||||||||||||||||
Detection: LC/MS |
Order Items Used in This Application
00F-4770-AN
bioZen 1.6 µm Peptide PS-C18, LC Column 150 x 2.1 mm, Ea
Qty:
Similar Applications
search
Tryptic Digest of Infliximab
bioZen 2.6 µm Peptide XB-C18, LC Column 150 x 2.1 mm, Ea
Reversed Phase
bioZen 2.6 µm Peptide XB-C18, LC Column 150 x 2.1 mm, Ea
Reversed Phase
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
